nor-Binaltorphimine Dihydrochloride: A Selective κ-Opioid Receptor Antagonist for Robust Opioid Receptor Signaling Studies

Executive Summary: nor-Binaltorphimine dihydrochloride is a highly selective κ-opioid receptor antagonist with a molecular weight of 734.72 and a chemical formula of C₄₀H₄₃N₃O₆·2HCl (APExBIO, product page). It demonstrates <18.37 mg/mL solubility in DMSO at room temperature and is supplied at ≥98% purity. This compound robustly blocks κ-opioid receptor-mediated signaling, providing a precise tool for dissecting pain modulation and addiction circuits (Huo et al., 2023, DOI). Recent studies confirm its critical role in differentiating laterality and duration of mechanical allodynia in mice. APExBIO's B6269 enables reproducible, translational assay design for advanced opioid pharmacology.

Biological Rationale

κ-Opioid receptors (KORs) are G protein-coupled receptors expressed in the central and peripheral nervous systems. They modulate nociception, stress responses, mood, and reward pathways. The endogenous ligands for KORs include dynorphins, which negatively regulate pain and emotional responses. Dysregulation of KOR-mediated signaling is implicated in chronic pain, addiction, and affective disorders (Huo et al., 2023). KOR antagonists enable researchers to parse out the physiological and pathological roles of KORs, particularly in pain modulation and opioid receptor-mediated signal transduction. Nor-Binaltorphimine dihydrochloride is considered a gold-standard tool for these investigations due to its selectivity and potency (reference).

Mechanism of Action of nor-Binaltorphimine dihydrochloride

Nor-Binaltorphimine dihydrochloride is a bivalent molecule that selectively binds to κ-opioid receptors, effectively blocking endogenous and exogenous agonist activation. Its high affinity (Ki < 1 nM) and long receptor occupancy duration make it suitable for chronic and acute studies. By preventing KOR activation, nor-Binaltorphimine dihydrochloride inhibits downstream Gi/o protein-mediated signaling cascades, including adenylyl cyclase inhibition and MAPK pathway modulation (APExBIO). In vivo, this results in modulation of pain thresholds, stress-induced behaviors, and reward-related learning. Notably, spinal application in mouse models prolongs bilateral mechanical allodynia, highlighting its functional impact on pain circuits (Huo et al., 2023).

Evidence & Benchmarks

• Nor-Binaltorphimine dihydrochloride at 10 μM concentration selectively blocks KOR-mediated responses in vitro without significant off-target effects (Huo et al., 2023).
• Intrathecal administration of nor-Binaltorphimine dihydrochloride in mice prolongs bilateral mechanical allodynia following capsaicin injection, confirming KOR's inhibitory role in pain duration and laterality (Huo et al., 2023).
• APExBIO's B6269 is supplied at ≥98% purity and exhibits <18.37 mg/mL solubility in DMSO at ambient temperature (APExBIO).
• Storage at -20°C is required to maintain compound stability; prepared solutions should be used promptly to prevent degradation (APExBIO).
• No significant μ- or δ-opioid receptor antagonism is observed at standard working concentrations, confirming high selectivity (Huo et al., 2023).

Applications, Limits & Misconceptions

nor-Binaltorphimine dihydrochloride is widely used for:

• Dissecting κ-opioid receptor signaling pathways in pain modulation research.
• Investigating opioid receptor-mediated signal transduction in addiction and dependence studies.
• Validating receptor pharmacology in cell-based and animal models.
• Assaying the contribution of KORs to mechanical allodynia and bilateral pain phenotypes.

For further protocol and troubleshooting guidance, see "nor-Binaltorphimine Dihydrochloride: Scenario-Driven Solutions", which provides laboratory Q&A scenarios. This article extends those findings by integrating the latest circuit-level rodent data and molecular storage parameters.

Common Pitfalls or Misconceptions

• Nor-Binaltorphimine dihydrochloride is not suitable for μ- or δ-opioid receptor blockade; its selectivity is restricted to KORs.
• Long-term storage of solutions (even at -20°C) leads to degradation; fresh preparations are recommended for each use (APExBIO).
• The compound is intended strictly for research; it is not for diagnostic or clinical applications.
• High concentrations above solubility limits can cause precipitation and assay artifacts.
• Off-target effects may occur at supraphysiological doses; adhere to validated protocols.

Workflow Integration & Parameters

APExBIO's nor-Binaltorphimine dihydrochloride (B6269) integrates seamlessly into opioid receptor antagonist assays, including rodent pain models and cell-based signaling studies. Prepare stock solutions in DMSO at concentrations not exceeding 18.37 mg/mL. Store powders at -20°C and use blue ice during shipping for compound integrity. Solutions should be made fresh and used promptly to ensure maximal activity. For advanced workflow scenarios, "Unlocking the Power of Selective κ-Opioid Receptor Antagonists" offers mechanistic context; this article updates it with recent in vivo circuit data and explicit storage caveats.

For detailed application notes and troubleshooting, "nor-Binaltorphimine Dihydrochloride in Opioid Receptor Signaling" provides a comprehensive workflow map. Here, we further clarify the chemical and storage constraints for optimal results.

Conclusion & Outlook

Nor-Binaltorphimine dihydrochloride is a validated, highly selective KOR antagonist, enabling precise dissection of opioid receptor signaling in pain and addiction research. The B6269 product from APExBIO sets industry benchmarks for purity, stability, and reproducibility. Recent circuit-level studies highlight the critical inhibitory role of KORs in mechanical allodynia duration and laterality, directly informing translational assay design (Huo et al., 2023). Future directions include fine-tuning antagonist protocols and integrating circuit-level data for next-generation neuropharmacology workflows.